22 April 2009
Simon Varcoe
simon.varcoe@informa.com
Merck & Co began the year with a poor first quarter with total sales falling by 8% to $5.39 billion and EPS more than halving to $0.67.
The company's net income fell by 57% to $1.46 billion, which it attributed to a $1.4 billion payment from
AstraZeneca recorded in the first quarter of last...
Please Login to read the full article.
RELATED CONTENT
ANALYSIS
Other Informa Analysis
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
